When mice lack BAP31 and drink alcohol, their livers can’t store sugar properly, leading to low blood sugar and less energy for the body.
Scientific Claim
BAP31 deficiency in mice is associated with a 35.7% reduction in hepatic glycogen content and a 40% decrease in Ppp1r3c expression following ethanol exposure, impairing glycogen synthesis and contributing to ethanol-induced hypoglycemia and metabolic dysregulation.
Original Statement
“Hepatic glycogen content was also reduced in BAP31-LKO mice, along with reduced Ppp1r3c expression, demonstrating impaired glycogen synthesis... Reduced PAS staining in WT mice confirmed glycogen depletion. BAP31 deficiency further reduced PAS staining under both basal and ethanol-treated conditions.”
Evidence Quality Assessment
Claim Status
appropriately stated
Study Design Support
Design supports claim
Appropriate Language Strength
association
Can only show association/correlation
Assessment Explanation
The study demonstrates clear associations between BAP31 loss, reduced Ppp1r3c, and lower glycogen in mice with ethanol exposure. Causation cannot be proven without rescue experiments, so 'associated with' is correct.
Gold Standard Evidence Needed
According to GRADE and EBM methodology, here is what ideal scientific evidence would look like to definitively prove or disprove this specific claim, ordered from strongest to weakest evidence.
Randomized Controlled TrialLevel 1bWhether restoring Ppp1r3c expression rescues glycogen storage and hypoglycemia in BAP31-deficient mice after ethanol.
Whether restoring Ppp1r3c expression rescues glycogen storage and hypoglycemia in BAP31-deficient mice after ethanol.
What This Would Prove
Whether restoring Ppp1r3c expression rescues glycogen storage and hypoglycemia in BAP31-deficient mice after ethanol.
Ideal Study Design
A double-blind RCT in 40 BAP31-LKO mice, randomized to receive AAV-mediated Ppp1r3c overexpression or control vector, followed by 6 g/kg ethanol; primary outcomes are hepatic glycogen content and serum glucose at 24h, with secondary outcomes of PAS staining and insulin signaling markers.
Limitation: Does not test if BAP31 directly regulates Ppp1r3c or if this pathway is relevant in humans.
Prospective Cohort StudyLevel 2bWhether low hepatic Ppp1r3c expression in humans correlates with glycogen depletion and hypoglycemia in alcoholic liver disease.
Whether low hepatic Ppp1r3c expression in humans correlates with glycogen depletion and hypoglycemia in alcoholic liver disease.
What This Would Prove
Whether low hepatic Ppp1r3c expression in humans correlates with glycogen depletion and hypoglycemia in alcoholic liver disease.
Ideal Study Design
Prospective cohort of 150 patients with ALD undergoing liver biopsy, measuring Ppp1r3c mRNA and protein levels, correlating with pre-biopsy fasting glucose, glycogen content (via histochemistry), and incidence of alcohol-induced hypoglycemia over 6 months.
Limitation: Cannot determine if Ppp1r3c downregulation is a cause or consequence of liver damage.
In Vitro StudyLevel 5In EvidenceWhether BAP31 knockdown in human hepatocytes directly reduces glycogen synthesis and Ppp1r3c expression under ethanol stress.
Whether BAP31 knockdown in human hepatocytes directly reduces glycogen synthesis and Ppp1r3c expression under ethanol stress.
What This Would Prove
Whether BAP31 knockdown in human hepatocytes directly reduces glycogen synthesis and Ppp1r3c expression under ethanol stress.
Ideal Study Design
Primary human hepatocytes from 15 donors, transfected with BAP31 siRNA or control, treated with 100 mM ethanol for 24h, measuring glycogen content via enzymatic assay and Ppp1r3c mRNA/protein levels, with 3 biological replicates and glucose uptake assays.
Limitation: Cannot replicate whole-body glucose homeostasis or hormonal feedback.
Evidence from Studies
Supporting (1)
Scientists found that mice without BAP31 couldn’t store sugar in their liver well after drinking alcohol, which matches what the claim says — BAP31 loss makes alcohol worse for liver sugar storage.